Cannabis HealthTech startups in Australia
There are 102 Cannabis HealthTech startups in Australia which include Creso Pharma, Neurotech International, Incannex, Little Green Pharma, Zelira Therapeutics. Out of these, 12 startups are funded, with 13 having secured Series A+ funding.
Over the past 10 years, an average of 6 new companies have been launched annually. Notably, several of these startups have been founded by alumni of Cornell University.
Here is the list of top Cannabis HealthTech startups in Australia
1. Creso Pharma
Developer of cannabinoid therapeutics for multiple health purposes. The company has developed therapeutics for human and veterinary applications using nanotechnology. The company's lead products are cannabidiol hemp oil-based complementary feed for companion animals and a nutraceutical for human health.
Key facts about Creso Pharma
- Founded Year: 2015
- Location: Perth (Australia)
- Stage: Acquired
- Investors: EverBlu Capital and L1 Capital
- Latest Funding Round: Post IPO, Oct 07, 2020, $*****
- Tracxn Score: 52/100 What is this?
- Competitors Rank: 24 of 1,555 Competitors
Developer of therapeutics for multiple paediatric neurological disorders. The company's product line include NTI164, is a broad-spectrum oral cannabinoid therapy targeting neuroinflammation in conditions like Autism Spectrum Disorder, Rett Syndrome, and PANDAS/PANS.
Key facts about Neurotech International
- Founded Year: 2016
- Location: Perth (Australia)
- Stage: Public
- Investors: Transcontinental Group
- Latest Funding Round: Post IPO, Oct 16, 2017, $*****
- Tracxn Score: 45/100 What is this?
- Competitors Rank: 9 of 46 Competitors
3. Incannex
Incannex is a clinical stage pharmaceutical company that specializes in the development of medicinal cannabinoid compounds and psychedelic therapies. They have a diversified portfolio of 28 FDA compliant R&D programs and are well positioned as a leader in the development of novel cannabinoid pharmaceuticals and psychedelic therapies.
Key facts about Incannex
- Founded Year: 2015
- Location: Melbourne (Australia)
- Stage: Public
- Latest Funding Round: Post IPO, Mar 10, 2025, $*****
- Tracxn Score: 39/100 What is this?
- Competitors Rank: 37 of 319 Competitors
Manufacturer of medicinal cannabis for therapeutic use. The company produces cannabis oils by extracting them from the whole plant along with medium-chain triglyceride (MCT) oil. The company's small particle formulations include Plus and Natural which are made using different ratios of tetrahydrocannabinol (THC) and cannabidiol (CBD). The company has also developed anti-solvent extraction technology ARISE that is used to increase the surface area of active pharmaceuticals to improve the drug absorption potential.
Key facts about Little Green Pharma
- Founded Year: 2016
- Location: Perth (Australia)
- Stage: Public
- Total Funding till date: $1.91M
- Investors: Fastforward Innovations
- Latest Funding Round: Post IPO, Mar 24, 2023, $*****
- Tracxn Score: 34/100 What is this?
- Competitors Rank: 31 of 281 Competitors
_1581685163059.png?format=webp&height=120&width=120){kind=logo}
Developer of cannabis-based therapeutics for multiple diseases. The company's drug pipeline includes Zenivol for insomnia, Sprinjene for oral care, and dermatology. Also provides drug candidates for cancer, autism, pain, aging disorders, and more.
Key facts about Zelira Therapeutics
- Founded Year: 2003
- Location: Perth (Australia)
- Stage: Public
- Investors: Thorney and Quincy Street Capital
- Latest Funding Round: Post IPO, Aug 18, 2023, $*****
- Tracxn Score: 33/100 What is this?
- Competitors Rank: 34 of 281 Competitors
